1. Novel compounds of the following formula I;
wherein R\u2550H, alkyl, alkylcarbonyl, (HO)2PO\u2014, alkyl-OPO(OH)\u2014, (alkyl-O)2PO\u2014, cycloalkyl, cycloalkylcarbonyl, aryl, arylcarbonyl, heterocyclyl and heterocyclyl carbonyl; or stereoisomer(s) or tautomer(s) or pharmaceutically acceptable salt(s) thereof.
2. A novel compound, PM 181104 as claimed in claim 1, wherein in the compounds of formula I, R is H; or a stereoisomer or a tautomer or a pharmaceutically acceptable salt thereof.
3. The novel compound, PM181104 as claimed in claim 2, or a stereoisomer or a tautomer thereof, having antibacterial activity, which compound is isolated from the fermented broth of the microorganism belonging to Kocuria species (ZMA B-IlMTCC 5269) and is characterised by:
(a) molecular weight of 1514,
(b) molecular formula C69H66N18O3S5,
(c) UV spectrum as depicted in FIG. 1,
(d) IR spectrum as depicted in FIG. 2,
(e) 1H NMR spectrum as depicted in FIG. 3,
(f) 13C NMR spectrum as depicted in FIG. 4.
4. A process for the production of the compound PM 181104 as claimed in claim 2, comprising the steps of:
(a) cultivating the microorganism Kocuria species (ZMA B-1MTCC 5269) or one of its variants or mutants under submerged aerobic conditions in a nutrient medium containing sources of carbon and nitrogen to produce the compound PM 181104,
(b) isolating the compound PM 181104 from the fermented broth, and
(c) purifying the compound PM181104.
5. A process as claimed in claim 4, further comprising the step of converting the compound PM 181104 to its pharmaceutically acceptable salt.
6. A process as claimed in claim 4, further comprising the step of reacting the compound PM181104 with an acid having the formula RCOOH; wherein R is alkyl, cycloalkyl, aryl or heterocyclyl, to obtain the novel compounds of formula I
wherein R\u2550H, alkyl, alkylcarbonyl, (HO)2PO\u2014, alkyl-OPO(OH)\u2014, (alkyl-O)2PO\u2014, cycloalkyl, cycloalkylcarbonyl, aryl, arylcarbonyl, heterocyclyl and heterocyclyl carbonyl; or stereoisomer(s) or tautomer(s) or pharmaceutically acceptable salt(s) thereof, wherein R=alkyl, cycloalkyl, aryl and heterocyclyl.
7. The compounds as claimed in claim 1 wherein
8. A pharmaceutical composition, comprising an effective amount of the compounds as claimed in claim 1, with at least one pharmaceutically acceptable excipient or an additive or an auxiliary.
9. The pharmaceutical composition as claimed in claim 8, wherein the pharmaceutical composition is in the form of a tablet, coated tablet, capsule, granule, powder, cream, ointment, gel, emulsion, suspension, or solution for injection.
10. A pharmaceutical composition as claimed in claim 8, wherein said composition is adapted for the treatment of bacterial infection.
11. The pharmaceutical composition as claimed in claim 10, wherein said bacterial infection is caused by bacteria belonging to Staphylococcus, Streptococcus, Enterococcus or Bacillus species.
12. The pharmaceutical composition as claimed in claim 11, wherein said bacteria belong to Staphylococcus or Enterococci species.
13. The pharmaceutical composition as claimed in claim 12, wherein said bacteria belonging to Staphylococcus species is methicillin-resistant.
14. The pharmaceutical composition as claimed in claim 12, wherein said bacteria belonging to Staphylococcus species is vancomycin-resistant.
15. The pharmaceutical composition as claimed in claim 12, wherein said bacteria belonging to Enterococci species is vancomycin-resistant.
16. A method of treating a bacterial infection comprising administering to a mammal in need thereof an effective amount of a compound as claimed in claim 1.
17. The method as claimed in claim 16, wherein the bacterial infection is caused by bacteria belonging to Staphylococcus, Streptococcus, Enterococci and Bacillus species.
18. The method as claimed in claim 17, wherein the bacterial infection is caused by bacteria belonging to Staphylococcus or Enterococci species.
19. The method as claimed in claim 18, wherein the said bacteria belonging to Staphylococcus species is methicillin-resistant.
20. The method as claimed in claim 18, wherein the said bacteria belonging to Staphylococcus species is vancomycin-resistant.
21. The method as claimed in claim 18, wherein the bacteria belonging to Enterococci species is vancomycin-resistant.
22. (canceled)
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A multi viewer display comprising:
a display unit comprising a plurality of pixels;
an image receiver which receives a plurality of image signals;
a signal processor which processes the plurality of image signals to allot and display the plurality of received image signals for each pixel of the display unit corresponding to a plurality of viewers; and
an optical angle converter which changes displayed light of the image signal displayed in each pixel of the display unit to be within a viewing angle range of each respective viewer among the plurality of viewers by changing a refraction of the displayed light.
2. The multi viewer display according to claim 1, wherein the optical angle converter comprises a liquid lens comprising a liquid that changes a photorefractive index according to an applied voltage.
3. The multi viewer display according to claim 1, wherein the optical angle converter comprises a polarization switch which sequentially converts a polarizing direction of incident light according to an applied voltage.
4. The multi viewer display according to claim 2, wherein the voltage applied to the optical angle converter is applied to pixels of the display unit by row or column.
5. The multi viewer display according to claim 3, wherein the voltage applied to the optical angle converter is applied to pixels of the display unit by row or column.
6. The multi viewer display according to claim 3, wherein the optical angle converter further comprises a birefringent element which transmits or refracts light in the polarizing direction of the light that has transmitted the polarization switch.
7. The multi viewer display according to claim 1, wherein the optical angle converter further comprises a lenticular lens corresponding to at least one pixel.
8. The multi viewer display according to claim 1, further comprising a viewer location detector which detects a location of the viewer.
9. The multi viewer display according to claim 8, wherein the optical angle converter changes the displayed light based on the detected location of the viewer.
10. The multi viewer display according to claim 1, wherein the plurality of image signals is allotted to alternating rows or columns of the pixels of the display unit.
11. The multi viewer display according to claim 10, wherein the plurality of image signals in the same row or column is separately displayed.
12. The multi viewer display according to claim 1, wherein the viewing angle range of the viewers is preset.
13. The multi viewer display according to claim 1, wherein the viewing angle range of the plurality of viewers does not overlap one another.
14. The multi viewer display according to claim 8, wherein the viewing angle range of the viewers is set on the basis of the detected location of the viewer.
15. The multi viewer display according to claim 12, further comprising a user interface (UI) generator which generates a UI for guiding the location of the viewer according to the set viewing angle range.
16. The multi viewer display according to claim 14, further comprising a user interface (UI) generator which generates a UI for guiding the location of the viewer according to the set viewing angle range.
17. The multi viewer display according to claim 1, wherein two adjacent pixels receive left eye image information and right eye image information with respect to one 3D image signal.
18. The multi viewer display according to claim 2, wherein the optical angle converter receives a uniform voltage to display single image information for a single viewer.
19. A displaying method of a multi viewer display comprising:
receiving a plurality of image signals;
processing the plurality of image signals to allot and display the plurality of received image signals in each pixel of a display unit corresponding to a plurality of viewers; and
changing displayed light of the image signals displayed in each pixel of the display unit to be within a viewing angle range of each respective viewer among the plurality of viewers by changing a refraction of the displayed light.
20. The displaying method according to claim 19, further comprising transmitting or refracting the changed displayed light in a polarizing direction.
21. The displaying method according to claim 19, further comprising detecting a location of the viewer.
22. The displaying method according to claim 21, wherein the changing is performed on the basis of the detected location of the viewer.
23. The displaying method according to claim 19, wherein the processing comprises allotting the plurality of image signals to alternating rows or columns of the pixels of the display unit.
24. The displaying method according to claim 23, wherein the plurality of image signals in the same row or column is separately displayed.
25. The displaying method according to claim 19, wherein the viewing angle range of the viewers is preset.
26. The displaying method according to claim 19, wherein the viewing angle range of the plurality of viewers does not overlap one another.
27. The displaying method according to claim 21, wherein the viewing angle range of the viewers is set on the basis of the detected location of the viewer.
28. The displaying method according to claim 25, further comprising a user interface (UI) generator which generates a UI for guiding the location of the viewer according to the set viewing angle range.
29. The displaying method according to claim 27, further comprising a user interface (UI) generator which generates a UI for guiding the location of the viewer according to the set viewing angle range.
30. The displaying method according to claim 19, wherein two adjacent pixels receive left eye image information and right eye image information with respect to one 3D image signal.